Cargando…

Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016

Detalles Bibliográficos
Autores principales:	New, Sarah, Winter, Kathleen, Boyte, Rebeca, Harriman, Kathleen, Gutman, Anya, Christiansen, Amber, Royce, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2018
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188120/ https://www.ncbi.nlm.nih.gov/pubmed/30260942 http://dx.doi.org/10.15585/mmwr.mm6738a6

Ejemplares similares

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea
por: Park, Hee-Jin, et al.
Publicado: (2019)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
por: Cho, Hye-Kyung, et al.
Publicado: (2021)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
por: Oliver, Sara E., et al.
Publicado: (2020)

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model
por: Prygiel, Marta, et al.
Publicado: (2023)

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
por: Castillo, Sonsire Fernández, et al.
Publicado: (2016)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Mass Spectrometric Analysis of Multiple Pertussis Toxins and Toxoids
por: Williamson, Yulanda M., et al.
Publicado: (2010)

An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
por: Rose, Markus A, et al.
Publicado: (2013)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Pertussis Epidemic — California, 2014
por: Winter, Kathleen, et al.
Publicado: (2014)

Attitudes of US Obstetricians Toward a Combined Tetanus-Diphtheria-Acellular Pertussis Vaccine for Adults
por: Clark, Sarah J., et al.
Publicado: (2006)

THE PURIFICATION AND CONCENTRATION OF DIPHTHERIA TOXOID
por: Wadsworth, Augustus, et al.
Publicado: (1932)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021)

Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies
por: Florea, Ana, et al.
Publicado: (2022)

Association of Diphtheria-Tetanus–Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children
por: Rane, Madhura S., et al.
Publicado: (2021)

Vaccination with Tetanus, Diphtheria, and Acellular Pertussis Vaccine of Pregnant Women Enrolled in Medicaid — Michigan, 2011–2013
por: Housey, Michelle, et al.
Publicado: (2014)

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

Half-life Estimation of Pertussis-Specific Maternal Antibodies in (Pre)Term Infants After In-Pregnancy Tetanus, Diphtheria, Acellular Pertussis Vaccination
por: Embacher, Stefan, et al.
Publicado: (2023)

Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2023)

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
por: Kwon, Hyo Jin, et al.
Publicado: (2017)

Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
por: Kang, Kyu Ri, et al.
Publicado: (2021)

Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care
por: Masseria, Cristina, et al.
Publicado: (2015)

Lichen planus following tetanus–diphtheria–acellular pertussis vaccination: A case report and review of the literature
por: Rosengard, Heather C, et al.
Publicado: (2018)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Tetanus toxoid immunization to reduce mortality from neonatal tetanus
por: Blencowe, Hannah, et al.
Publicado: (2010)

Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients
por: Boey, Lise, et al.
Publicado: (2021)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

153. The Effect of Timing of Tetanus–Diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies
por: Raya, Bahaa Abu, et al.
Publicado: (2018)

Mass Spectrometry-Based Quantification of the Antigens in Aluminum Hydroxide-Adjuvanted Diphtheria-Tetanus-Acellular-Pertussis Combination Vaccines
por: van der Maas, Larissa, et al.
Publicado: (2022)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ufs0q64teq1t1vdk45nd9spln